Identification of CDKN3 overexpression as a marker of poor prognosis and potential therapeutic target in low-grade glioma
Abstract Low-grade glioma (LGG) is a primary, slow-growing brain tumor; however, its treatment and prognosis remain challenging. In this study, we analyzed cancer data from the TCGA database, focusing particularly on the expression of the CDKN3 gene in LGG. The results showed that high CDKN3 express...
Saved in:
Main Authors: | Hongbing Cheng, Xiao Meng, Yanhua Zhang, Pu Wang, Yucheng Lu |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2025-01-01
|
Series: | Scientific Reports |
Subjects: | |
Online Access: | https://doi.org/10.1038/s41598-025-86338-8 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prognostic factors of thalamic and thalamopeduncular low-grade gliomas in children: A systematic review and recommendations for surgical management
by: Jana Táborská, et al.
Published: (2025-01-01) -
Expression and prognostic value of ferritinophagy-related NCOA4 gene in low-grade glioma: integration of bioinformatics and experimental validation
by: Guangtang Chen, et al.
Published: (2025-01-01) -
Cinnamaldehyde impacts key cellular signaling pathways for induction of programmed cell death in high-grade and low-grade human glioma cells
by: Yoo Na Kim, et al.
Published: (2025-01-01) -
Identification of critical biomarkers and immune landscape patterns in glioma based on multi-database
by: Hanzhang Yuan, et al.
Published: (2025-01-01) -
Deciphering the Differences Between Epstein–Barr Virus‐Associated and Negative Gastric Cancer in the Prospect of CDKN2A Genomic Alterations and Lymphoid Infiltration
by: Fuda Xie, et al.
Published: (2025-01-01)